Derivation of human embryonic stem cell line Genea019

Stem Cell Res. 2016 Mar;16(2):397-400. doi: 10.1016/j.scr.2016.02.008. Epub 2016 Feb 3.

Abstract

The Genea019 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, through ICM outgrowth on inactivated feeders. The line showed pluripotent cell morphology and genomic analysis verified a 46, XX karyotype, female Allele pattern and unaffected Htt CAG repeat length, compared to HD affected sibling Genea020. Pluripotency of Genea019 was demonstrated with 75% of cells expressing Nanog, 89% Oct4, 48% Tra1-60 and 85% SSEA4, a Pluritest Pluripotency score of 22.97, Novelty score of 1.42, tri-lineage teratoma formation and Alkaline Phosphatase activity. The cell line was negative for Mycoplasma and any visible contamination.

MeSH terms

  • Alleles
  • Animals
  • Blastocyst / cytology*
  • Cell Differentiation
  • Cells, Cultured
  • Cellular Reprogramming
  • Comparative Genomic Hybridization
  • Female
  • Human Embryonic Stem Cells / cytology*
  • Human Embryonic Stem Cells / metabolism
  • Human Embryonic Stem Cells / transplantation
  • Humans
  • Karyotype
  • Mice
  • Microscopy, Fluorescence
  • Teratoma / metabolism
  • Teratoma / pathology
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transplantation, Heterologous

Substances

  • Transcription Factors